Antibody-free LC-MS/MS quantification of rhTRAIL in human and mouse serum

Analytical Chemistry

Volumn 85, Issue 22, 2013, Pages 10754-10760

  Wilffert, Daniel ^a   Reis, Carlos R ^a,d   Hermans, Jos ^a   Govorukhina, Natalia ^a   Tomar, Tushar ^b   De Jong, Steven ^b   Quax, Wim J ^a   Van De Merbel, Nico C ^a,c   Bischoff, Rainer ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c PRA Health Sciences   (Netherlands)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSOLUTE QUANTIFICATION; BIOPHARMACEUTICAL PROTEINS; CONCENTRATION RANGES; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; LABELED INTERNAL STANDARDS; LOWER LIMIT OF QUANTIFICATIONS; PHARMACOKINETIC STUDIES;

AFFINITY CHROMATOGRAPHY; AMINO ACIDS; BODY FLUIDS; CELL DEATH; PEPTIDES;

RECOMBINANT PROTEINS;

METHIONINE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

AFFINITY CHROMATOGRAPHY; ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CHEMISTRY; HUMAN; LIQUID CHROMATOGRAPHY; METHODOLOGY; MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS; TANDEM MASS SPECTROMETRY;

ANIMALS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; METHIONINE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECOMBINANT PROTEINS; TANDEM MASS SPECTROMETRY;

EID: 84888377111     PISSN: 00032700     EISSN: 15206882     Source Type: Journal    
DOI: 10.1021/ac4017902     Document Type: Article

References (32)

1. Fesik, S. W. Nat. Rev. Cancer 2005, 5, 876-885
2. Ashkenazi, A.; Holland, P.; Eckhardt, S. G. Am. J. Clin. Oncol. 2008, 26, 3621-3630
3. Ashkenazi, A.; Pai, R. C.; Fong, S.; Leung, S.; Lawrence, D. A.; Marsters, S. A.; Blackie, C.; Chang, L.; McMurtrey, A. E.; Hebert, A.; DeForge, L.; Koumenis, I. L.; Lewis, D.; Harris, L.; Bussiere, J.; Koeppen, H.; Shahrokh, Z.; Schwall, R. H. J. Clin. Invest. 1999, 104, 155-162
4. LeBlanc, H. N.; Ashkenazi, A. Cell Death Differ. 2003, 10, 66-75
5. Van der Sloot, A. M.; Tur, V.; Szegezdi, E.; Mullally, M. M.; Cool, R. H.; Samali, A.; Serrano, L.; Quax, W. J. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 8634-8639
6. Reis, C. R.; Van der Sloot, A. M.; Natoni, A.; Szegezdi, E.; Setroikromo, R.; Meijer, M.; Sjollema, K.; Stricher, F.; Cool, R. H.; Samali, A.; Serrano, L.; Quax, W. J. Cell. Death Dis. 2010, 1 e83
7. Duiker, E. W.; De Vries, E. G. E.; Mahalingam, D.; Meersma, G. J.; Boersma-van Ek, W.; Hollema, H.; Lub-de Hooge, M. N.; Van Dam, G. M.; Cool, R. H.; Quax, W. J.; Samali, A.; Van der Zee, A. G. J.; De Jong, S. Clin. Cancer Res. 2009, 15, 2048-2057
8. Ezan, E.; Dubois, M.; Becher, F. Analyst 2009, 134, 825-834
9. Bischoff, R.; Bronsema, K. J.; Van de Merbel, N. C. Trends Anal. Chem. 2013, 48, 41-51
10. Hoofnagle, A. N.; Wener, M. H. J. Immunol. Methods 2009, 347, 3-11
11. Lange, V.; Picotti, P.; Domon, B.; Aebersold, R. Mol. Syst. Biol. 2008, 4, 222
12. Brun, V.; Dupuis, A.; Adrait, A.; Marcellin, M.; Thomas, D.; Court, M.; Vandenesch, F.; Garin, J. Mol. Cell. Proteomics 2007, 6, 2139-2149
13. Brun, V.; Masselon, C.; Garin, J.; Dupuis, A. Proteomics 2009, 72, 740-749
14. Bronsema, K. J.; Bischoff, R.; Van de Merbel, N. C. J. Chromatogr., B 2012, 893-894, 1-14
15. Reis, C. R.; Van der Sloot, A. M.; Szegezdi, E.; Natoni, A.; Tur, V.; Cool, R. H.; Samali, A.; Serrano, L.; Quax, W. J. Biochemistry 2009, 48, 2180-2191
16. Wu, X.; Koiwa, H. Anal. Biochem. 2012, 421, 347-349
17. Yan, J. X.; Wait, R.; Berkelman, T.; Harry, R. A.; Westbrook, J. A.; Wheeler, C. H.; Dunn, M. J. Electrophoresis 2000, 21, 3666-3672
18. Franciosi, L.; Govorukhina, N.; Ten Hacken, N.; Postma, D.; Bischoff, R. Methods Mol. Biol. 2011, 790, 17-28
19. Boichenko, A.; Govorukhina, N.; Van der Zee, A. G. J.; Bischoff, R. Anal. Bioanal. Chem. 2013, 405, 3195-3203
20. Kelley, S. K.; Harris, L. A.; Xie, D.; Deforge, L.; Totpal, K.; Bussiere, J.; Fox, J. A. J. Pharmacol. Exp. Ther. 2001, 299, 31-38
21. Strohalm, M.; Kavan, D.; Novák, P.; Volný, M.; Havlícek, V. Anal. Chem. 2010, 82, 4648-4651
22. MacLean, B.; Tomazela, D. M.; Shulman, N.; Chambers, M.; Finney, G. L.; Frewen, B.; Kern, R.; Tabb, D. L.; Liebler, D. C.; MacCoss, M. J. Bioinformatics 2010, 26, 966-968
23. Duan, X.; Young, R.; Straubinger, R. M.; Page, B.; Cao, J.; Wang, H.; Yu, H.; Canty, J. M.; Qu, J. J. Proteome Res. 2009, 8, 2838-2850
24. Lub-de Hooge, M. N.; De Vries, E. G. E.; De Jong, S.; Bijl, M. Ann. Rheum. Dis. 2005, 64, 854-858
25. Simon, R.; Girod, M.; Fonbonne, C.; Salvador, A.; Clément, Y.; Lantéri, P.; Amouyel, P.; Lambert, J. C.; Lemoine, J. Mol. Cell. Proteomics 2012, 11, 1389-1403
26. Sharma, S.; Agarwal, G. P. Anal. Biochem. 2001, 288, 126-140
27. Cheung, R. C. F.; Wong, J. H.; Ng, T. B. Appl. Microbiol. Biotechnol. 2012, 96 (6) 1411-1420
28. Kuo, W.-H. K.; Chase, H. A. Biotechnol. Lett. 2011, 33, 1075-1084
29. US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for Industry: Bioanalytical Method Validation; Center for Drug Evaluation and Research: Rockville, MD, May 2001.
30. European Medicines Agency, Committee for Medicinal Products for Human Use. Guideline on bioanalytical method validation; European Medicines Agency: London, July 2011.
31. Ageîncia Nacional de Vigilaîncia Sanitária. Resolução-RDC No 27; Ageîncia Nacional de Vigilaîncia Sanitária: Brazil, May 2012.
32. Soria, J.-C.; Smit, E.; Khayat, D.; Besse, B.; Yang, X.; Hsu, C.-P.; Reese, D.; Wiezorek, J.; Blackhall, F. Am. J. Clin. Oncol. 2010, 28, 1527-1533